Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Intrahepatic Cholangiocarcinoma”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128290
What this trial is testing

PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Federation Francophone de Cancerologie Digestive 49
Not applicableNot Yet RecruitingNCT07454486
What this trial is testing

TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

Who this might be right for
Biliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Gall Bladder Cancer+11 more
Aarhus University Hospital 300
Not applicableStudy completedNCT06381648
What this trial is testing

Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)

Who this might be right for
CholangiocarcinomaCholangiocarcinoma, IntrahepaticCholangiocarcinoma Resectable+1 more
City of Hope Medical Center 230
Early research (Phase 1)Ended earlyNCT01525069
What this trial is testing

Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaLiver Neoplasms
Washington University School of Medicine 27
Testing effectiveness (Phase 2)UnknownNCT04506281
What this trial is testing

PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 128
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07639528
What this trial is testing

Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma
Northwestern University 44
Testing effectiveness (Phase 2)Ended earlyNCT06739252
What this trial is testing

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Perihilar Cholangiocarcinoma
Peking University 1
Not applicableStudy completedNCT05874934
What this trial is testing

Endoscopic Drainage of Presumed Resectable pCCA Using an Intrahepatic Plastic Stent With Retrieval String

Who this might be right for
Perihilar Cholangiocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40
Not applicableLooking for participantsNCT06098547
What this trial is testing

LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA)

Who this might be right for
Intrahepatic Cholangiocarcinoma
Azienda Sanitaria Ospedaliera 10
Testing effectiveness (Phase 2)Study completedNCT03044587
What this trial is testing

Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer

Who this might be right for
Adenocarcinoma MetastaticBiliary Tract CancerAdenocarcinoma of the Biliary Tract+4 more
AIO-Studien-gGmbH 93
Testing effectiveness (Phase 2)Looking for participantsNCT06296563
What this trial is testing

Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Lei ZHAO 20
Not applicableLooking for participantsNCT03823144
What this trial is testing

Intravital Microscopy in Human Solid Tumors

Who this might be right for
Solid Tumor, AdultClinical Stage IV Gastric Cancer AJCC v8Malignant Solid Neoplasm+20 more
Mayo Clinic 85
Testing effectiveness (Phase 2)WithdrawnNCT06017297
What this trial is testing

Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma

Who this might be right for
Borderline Resectable CarcinomaBiliary Tract Cancer
Georgetown University
Testing effectiveness (Phase 2)UnknownNCT05620498
What this trial is testing

Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.

Who this might be right for
Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)UnknownNCT06192784
What this trial is testing

Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectable
Tongji Hospital 36
Testing effectiveness (Phase 2)WithdrawnNCT05514912
What this trial is testing

Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial

Who this might be right for
Resectable Intrahepatic CholangiocarcinomaStage 0 Intrahepatic Cholangiocarcinoma AJCC v8Stage I Intrahepatic Cholangiocarcinoma AJCC v8+2 more
Emory University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06903273
What this trial is testing

Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaBiliary Tract Cancer (BTC)
National Cheng-Kung University Hospital 35
Not applicableNo Longer AvailableNCT03414489
What this trial is testing

Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)

Who this might be right for
CholangiocarcinomaCholangiocarcinoma Non-resectableCholangiocarcinoma, Perihilar+2 more
RedHill Biopharma Limited
Testing effectiveness (Phase 2)Looking for participantsNCT06192797
What this trial is testing

Combined HAIC, Lenvatinib and Pucotenlimab As Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectable
Tongji Hospital 36
Testing effectiveness (Phase 2)UnknownNCT05672537
What this trial is testing

Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk

Who this might be right for
DurvalumabIntrahepatic CholangiocarcinomaGemcis
Tianjin Medical University Cancer Institute and Hospital 70
Load More Results